Abstract
Objective: To develop a pH responsive drug delivery system (DDS) for controlled release of therapeutic cargo, Doxazosin Mesylate (DZM) which was loaded into carrier material mesoporous silica nanoparticle (MSN) and subsequently coated with Eudragit S-100(ES-100) to release the drug at pH 7.4.
Material and Methods: We have synthesized cylindrical MSN under acidic condition using non-ionic surfactant (Pluronic® P 123) and Tetraethoxysilane (TEOS). After post synthesis treatment (PST) surfactant was removed by calcination. To obtain pH sensitive release calcined MSN was coated with ES-100 (MSN-DZMES100). The Brauner-Emmett-Teller (BET) surface area, adsorption isotherm, t-plot, pore volume of MSN were done in surface area analyzer to characterize different MSN samples (as synthesized, calcined, and coated).
Result and Discussion: Highest surafce area (427.114 m2/g) was observed in case of calcined sample when compared to as synthesized (3.1198m2/g) and coated MSN (8.8480m2/g). Adsorption pore width of final coated sample was 12.58 nm whereas as synthesized and calcined samples possessed pore width 36.82 nm and 7.32 nm respectively. All uncoated and coated MSN samples were further characterized with FESEM, TEM, FTIR. No significant interaction between drug and MSN was found from FTIR studies. The drug loading into coated mesoporous support was found to be 43.7%. In vitro studies were done at different pH using Franz-diffusion cell. Results showed significant release at pH 7.4 from MSNDZM- ES100. Cumulative drug release over a period of 10 hr was 81% at this systemic pH.
Conclusion: ES-100 coated mesoporous silica nanoparticle is a smart carrier for pH responsive release of guest molecule.
Keywords: Calcination, Eudragit S 100, Franz-diffusion cell, Mesoporous silica nanoparticles, pH responsive coating.
Current Drug Delivery
Title:In Vitro Evaluation of pH Responsive Doxazosin Loaded Mesoporous Silica Nanoparticles: A Smart Approach in Drug Delivery
Volume: 13 Issue: 4
Author(s): Arijit Guha, Nikhil Biswas, Kaustav Bhattacharjee, Piu Das and Ketousetuo Kuotsu
Affiliation:
Keywords: Calcination, Eudragit S 100, Franz-diffusion cell, Mesoporous silica nanoparticles, pH responsive coating.
Abstract: Objective: To develop a pH responsive drug delivery system (DDS) for controlled release of therapeutic cargo, Doxazosin Mesylate (DZM) which was loaded into carrier material mesoporous silica nanoparticle (MSN) and subsequently coated with Eudragit S-100(ES-100) to release the drug at pH 7.4.
Material and Methods: We have synthesized cylindrical MSN under acidic condition using non-ionic surfactant (Pluronic® P 123) and Tetraethoxysilane (TEOS). After post synthesis treatment (PST) surfactant was removed by calcination. To obtain pH sensitive release calcined MSN was coated with ES-100 (MSN-DZMES100). The Brauner-Emmett-Teller (BET) surface area, adsorption isotherm, t-plot, pore volume of MSN were done in surface area analyzer to characterize different MSN samples (as synthesized, calcined, and coated).
Result and Discussion: Highest surafce area (427.114 m2/g) was observed in case of calcined sample when compared to as synthesized (3.1198m2/g) and coated MSN (8.8480m2/g). Adsorption pore width of final coated sample was 12.58 nm whereas as synthesized and calcined samples possessed pore width 36.82 nm and 7.32 nm respectively. All uncoated and coated MSN samples were further characterized with FESEM, TEM, FTIR. No significant interaction between drug and MSN was found from FTIR studies. The drug loading into coated mesoporous support was found to be 43.7%. In vitro studies were done at different pH using Franz-diffusion cell. Results showed significant release at pH 7.4 from MSNDZM- ES100. Cumulative drug release over a period of 10 hr was 81% at this systemic pH.
Conclusion: ES-100 coated mesoporous silica nanoparticle is a smart carrier for pH responsive release of guest molecule.
Export Options
About this article
Cite this article as:
Guha Arijit, Biswas Nikhil, Bhattacharjee Kaustav, Das Piu and Kuotsu Ketousetuo, In Vitro Evaluation of pH Responsive Doxazosin Loaded Mesoporous Silica Nanoparticles: A Smart Approach in Drug Delivery, Current Drug Delivery 2016; 13 (4) . https://dx.doi.org/10.2174/1567201812666150722123704
DOI https://dx.doi.org/10.2174/1567201812666150722123704 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |
Call for Papers in Thematic Issues
Advancements in Robotic and AI-Based Drug Discovery and Delivery for Neurological Disorders
Neurological disorders, including Alzheimer's disease, Parkinson's disease, epilepsy, and brain tumors, pose significant challenges in drug delivery due to the blood-brain barrier's intricate structure and the complexity of neuronal networks. Traditional drug delivery methods often fall short in reaching therapeutic concentrations within the central nervous system, limiting treatment efficacy and ...read more
Advances of natural products, bio-actives and novel drug delivery system against emerging viral infections
Due to the increasing prevalence of viral infections and the ability of these human pathogens to develop resistance to current treatment strategies, there is a great need to find and develop new compounds to combat them. These molecules must have low toxicity, specific activity and high bioavailability. The most suitable ...read more
Electrospun Fibers as Drug Delivery Systems
In recent years, electrospun fibers have attracted considerable attention as potential platforms for drug delivery due to their distinctive properties and adaptability. These fibers feature a notable surface area-to-volume ratio and can be intentionally designed with high porosity, facilitating an increased capacity for drug loading and rendering them suitable for ...read more
Emerging Nanotherapeutics for Mitigation of Neurodegenerative Disorders
Conditions affecting the central nervous system (CNS) present a significant hurdle due to limited access to both treatments and diagnostic tools for the brain. The blood-brain barrier (BBB) acts as a barrier, restricting the passage of molecules from the bloodstream into the brain. The most formidable challenge facing scientists is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Multifactorial Regulation of GPER Expression in Cancer Cells and Cardiomyocytes
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Aliskiren: A Novel Renin Inhibitor for Hypertension
Current Drug Therapy Integrating Care for Older Adults with Cognitive Impairment
Current Alzheimer Research Adipose Tissue Oxygenation in Obesity: A Matter of Cardiovascular Risk?
Current Pharmaceutical Design Oleanolic Acid and Related Triterpenoids from Olives on Vascular Function: Molecular Mechanisms and Therapeutic Perspectives
Current Medicinal Chemistry Psychosomatic Disorder: The Current Implications and Challenges
Cardiovascular & Hematological Agents in Medicinal Chemistry How Would Composite Traditional Chinese Medicine Protect the Brain – An Example of the Composite Formula “Pien Tze Huang”
Current Medicinal Chemistry Ginger and Heart Health: From Mechanisms to Therapeutics
Current Molecular Pharmacology Nano-constructed Carriers Loaded With Antioxidant: Boon For Cardiovascular System
Current Pharmaceutical Design Immune Thrombocytopenic Purpura: New Biological Therapy of an Old Disease
Current Medicinal Chemistry Cerebral Vascular Aging: Extending the Concept of Pulse Wave Encephalopathy Through Capillaries to the Cerebral Veins
Current Aging Science Recent Findings Confirm LIM Domain Kinases as Emerging Target Candidates for Cancer Therapy
Current Cancer Drug Targets Value of Carnitine Therapy in Kidney Dialysis Patients and Effects on Cardiac Function from Human and Animal Studies
Current Drug Targets Anti-hypertensive Effects of Diminazene Aceturate: An Angiotensin- Converting Enzyme 2 Activator in Rats
Protein & Peptide Letters Peripheral Vascular Disease is Associated with Impaired Activities of Daily Living in the Elderly with Dementia: A Prospective Study
CNS & Neurological Disorders - Drug Targets Anaphylaxis in Risky Populations
Current Pharmaceutical Design The Effect of Menopause and Menopausal Hormone Therapy on the Risk of Peripheral Artery Disease
Current Vascular Pharmacology Acknowledgements to Reviewers
Current Hypertension Reviews Uveitis in Horses, Rats and Man: What Do We Learn from Our Pets?
Current Immunology Reviews (Discontinued) Characterizing the Binding of Angiotensin Converting Enzyme I Inhibitory Peptide to Human Hemoglobin: Influence of Electromagnetic Fields
Protein & Peptide Letters